Intravenous immunoglobulin - New indications and mechanisms of action

被引：4
|
作者：
Shoenfeld, Y [1 ]
Gershwin, ME
机构：
[1] Chaim Sheba Med Ctr, Dept Internal Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Res Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Laura Schwarz Kipp Chair Res Autoimmun Dis, IL-69978 Tel Aviv, Israel
[5] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
来源：
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 2005年 / 29卷 / 03期
关键词：
Thrombocytopenia; Purpura; Clinical Review; Intravenous Immunoglobulin; Immunology Volume;
D O I：
10.1385/CRIAI:29:3:165
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：165 / 166
页数：2
相关论文
共 50 条
  • [21] Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders
    Claire Larroche
    Youri Chanseaud
    Paloma Garcia de la Pena-Lefebvre
    Luc Mouthon
    [J]. BioDrugs, 2002, 16 : 47 - 55
  • [22] Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    J. Bayry
    M. Thirion
    N. Misra
    N. Thorenoor
    S. Delignat
    S. Lacroix-Desmazes
    B. Bellon
    S. Kaveri
    M. D. Kazatchkine
    [J]. Neurological Sciences, 2003, 24 : s217 - s221
  • [23] Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
    VIR-SINGH NEGI
    SRIRAMULU ELLURU
    SOPHIE SIBÉRIL
    STÉPHANIE GRAFF-DUBOIS
    LUC MOUTHON
    MICHEL D. KAZATCHKINE
    SÉBASTIEN LACROIX-DESMAZES
    JAGADEESH BAYRY
    SRINI V. KAVERI
    [J]. Journal of Clinical Immunology, 2007, 27 : 233 - 245
  • [24] Physiopathology of polymyositis and dermatomyositis - Action mechanisms of intravenous immunoglobulin
    Mouthon, L
    [J]. REVUE DE MEDECINE INTERNE, 2004, 25 : 10 - 12
  • [25] Mechanisms of action of intravenous immunoglobulin (IVIg) in autoimmune and neuromuscular diseases
    Sharshar, T
    Kaveri, S
    Kazatchkine, M
    [J]. CLINICAL NEUROPHYSIOLOGY: FROM RECEPTORS TO PERCEPTION, 1999, 50 : 486 - 492
  • [26] Mechanisms of action of intravenous immunoglobulin in immune-mediated diseases
    Kazatchkine, MD
    [J]. INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 29 - 41
  • [27] INDICATIONS FOR EVALUATION OF IMMUNOGLOBULIN CONCENTRATIONS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY
    STIEHM, ER
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (04) : 305 - 306
  • [28] IVIG - Mechanisms of Action, Indications and new Guidelines
    Enk, A.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 61 - 61
  • [29] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (HDIVIG) TREATMENT OF IMMUNE-MEDIATED BLOOD CYTOPENIAS - MECHANISMS OF ACTION, INDICATIONS AND RESULTS
    AYMARD, JP
    FERRY, R
    JANOT, C
    SCHOONEMAN, F
    STREIFF, F
    [J]. ANNALES DE MEDECINE INTERNE, 1990, 141 (08): : 689 - 697
  • [30] Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies
    Mouthon, L.
    Bussone, G.
    Kaveri, S.
    [J]. REVUE DE MEDECINE INTERNE, 2009, 30 : 14 - 20
12345